Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over

NCT02355379 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

774

Enrollment

OTHER

Sponsor class

Conditions

Colonic Adenocarcinoma

Interventions

DRUG: LV5FU2 or capectitabine
DRUG: FOLFOX4 or XELOX
OTHER: Observation
DRUG: LV5FU2 or capecitabine

Sponsor

Federation Francophone de Cancerologie Digestive